This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
In this recent report, researchers in the United States conducted a study To describe how molecular and genetic markers influence the response to therapy in patients with advanced non-small-cell lung cancer (NSCLC). Cisplatin resistance has been associated with high rates of expression of endonucleases, a family of DNA repair proteins that includes ERCC1 and BRCA1.
We care about your feedback. Let us know how we can improve your CancerCompass experience.